Characterization of a t(10;12)(q24;p13) in a case of CML in transformation

Genes Chromosomes and Cancer

Volumn 20, Issue 4, 1997, Pages 408-411

  Aguiar, Ricardo C T ^a   Chase, Andrew ^a   Oscier, David G ^b   Carapeti, Melina ^a   Goldman, John M ^a   Cross, Nicholas C P ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLAST CELL CRISIS; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 10; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SOUTHERN BLOTTING; YEAST ARTIFICIAL CHROMOSOME;

EID: 0030698269     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199712)20:4<408::AID-GCC13>3.0.CO;2-I     Document Type: Article

References (20)

1. Aguiar RCT, Dahia PLM, Bendit I, Beider B, Dorlhiac P, Bydlowisk S, Chamone D (1995) Further evidence for the lack of relation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation. Cancer Genet Cytogenet 84:105-112.
2. Baens M, Peeters P, Guo C, Aerssens J, Marynen P (1996) Genomic organisation of TEL: The human ETS-variant gene 6 (ETV6). Genome Res 6:404-413.
3. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel AG, Riegman P, Deprez RL, Zwarthoff E, Hagemeijer A, Grosveld G (1995) Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511-1519.
4. Elledge SJ, Winston J, Harper JW (1996) A question of balance - the role of cyclin kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388-392.
5. Golub TR, Barker GF, Lover M, Gilliland DG (1994) Fusion of PDGF receptor β to a novel ets-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307-316.
6. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996) Molecular characterization of 12p abnormalities in hematologic malignacies: deletions of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330.
7. Kempski H, Macdonald D, Michalski AJ, Roberts T, Goldman JM, Cross NCP, Cowell JK (1995) Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5Mbp region of chromosome 13. Genes Chromosomes Cancer 12:283-287.
8. Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci USA 88:8900-8904.
9. Kobayashi H, Montgomery KT, Bohlander SK, Adra CN, Lim BL, Kucherlapati RS, Donis-Keller H, Holt MS, Le Beau MM, Rowley JD (1994) Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 84:3473-3482.
10. Krauter K, Montgomery K, Yoon S-J, LeBlanc-Straceski J, Renault B, Marondel I, Herdman V, Cupelli L, Banks A, Lieman J, Menninger J Bray-Ward P, Nadkarni P, Weissenbach J, Le Paslier D, Rigault P, Chumakov I, Cohen D, Miller P, Ward D, Kucherlapati R (1995) A second-generation YAC contig map of human chromosome 12. Nature 377:321-333.
11. Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang C-C, Antonacci R, Fracchiolla NS, Ciana P, Maiolo AT, Neri A (1994) Heterogenous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood 84:3850-3860.
12. Mitelman F (1994) Catalog of Chromosome Aberrations in Cancer. 5th Ed. New York: Wiley-Liss, Inc.
13. Moschonas NK, Spurr NK, Mao J (1996) Report of the first international workshop on human chromosome 10 mapping 1995. Cytogenet Cell Genet 72:99-112.
14. Neri A, Chang C-C, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RSK, Dalla-Favera R (1991) B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
15. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34-38.
16. Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB (1986) Nonrandon involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 68:69-75.
17. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 85:3662-3670.
18. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland G, Davis EM, Le Beau M, Roberts JM, Vogelstein B, Rowley JD, Bohlander SK (1995) TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86:1525-1533.
19. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H (1995) TEL gene is involved in myelodysplatic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 85:2848-2852.
20. Wlodarska I, Baens M, Peeters P, Aerssens J, Mecucci C, Brock P, Marynen P, Van den Berghe H (1996) Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case. Cancer Res 56:2655-2661.